Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of "Hold" by Brokerages

Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) has received a consensus rating of "Hold" from the six research firms that are covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $52.33.

OMCL has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Omnicell from $37.00 to $44.00 and gave the stock a "neutral" rating in a report on Thursday, November 21st. StockNews.com raised shares of Omnicell from a "hold" rating to a "buy" rating in a report on Thursday, March 6th. Benchmark reaffirmed a "buy" rating and issued a $62.00 target price on shares of Omnicell in a report on Tuesday, February 4th. Wells Fargo & Company dropped their price target on Omnicell from $49.00 to $40.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Finally, Bank of America reduced their price objective on Omnicell from $54.00 to $46.00 and set a "neutral" rating on the stock in a research note on Monday, January 6th.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its position in shares of Omnicell by 51.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company's stock valued at $35,000 after acquiring an additional 273 shares during the period. Johnson Financial Group Inc. acquired a new stake in Omnicell in the fourth quarter valued at approximately $37,000. Van ECK Associates Corp grew its holdings in Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company's stock valued at $44,000 after purchasing an additional 315 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Omnicell in the fourth quarter valued at approximately $53,000. Finally, First Horizon Advisors Inc. raised its stake in shares of Omnicell by 36.3% during the 4th quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company's stock worth $59,000 after buying an additional 355 shares during the period. 97.70% of the stock is currently owned by hedge funds and other institutional investors.

Omnicell Trading Down 3.2 %

Omnicell stock opened at $32.28 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 0.13. Omnicell has a 12-month low of $25.12 and a 12-month high of $55.75. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 119.56, a P/E/G ratio of 7.53 and a beta of 0.85. The firm has a 50 day moving average of $40.96 and a 200 day moving average of $43.38.

Remove Ads

Omnicell (NASDAQ:OMCL - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a net margin of 1.13% and a return on equity of 3.82%. As a group, research analysts predict that Omnicell will post 1.09 earnings per share for the current year.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.